Review



mouse anti human ago2 monoclonal antibody  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc mouse anti human ago2 monoclonal antibody
    Figure 9. Anisomycin attenuates the molecular sponge effect in the lncRNA‑Meg3/miR‑421/PDGFRA axis. (A) Heatmap showing that the expression of lncRNA‑Meg3 in the anisomycin‑treated group was significantly lower than that of the control group. (B) Expression levels in clinical tumour samples and (C) in xenograft tumours suggest an inverse trend in expression for lncRNA‑Meg3 and miR‑421. (D) Expression levels of miR‑421 in HuOCSCs following anisomycin treatment. **P<0.01 vs. non‑treated (n=4). (E) Schematic of the complementary sites of mature miR‑421 and the 3’UTR of lncRNA‑Meg3 and PDGFRA mRNA. (F) Schematic of the structure of luciferase reporter plasmids. (G) The molecular sponge effect of lncRNA‑Meg3/miR‑421/PDGFRA. (H‑J) Results of the luciferase reporter assays. **P<0.01 vs. blank plasmid (n=3). (K) RIP results revealed that the binding between Meg3 and <t>Ago2</t> decreased significantly following treatment of HuOCSCs with anisomycin. lncRNA, long non‑coding RNA; Meg3, maternally expressed 3; miR, microRNA; PDGFRA, platelet derived growth factor receptor α; HuOCSCs, human ovarian cancer stem cells; RIP, RNA immunoprecipitation; Ago2, argonaute 2; ORF, open reading frame; UTR, untranslated region; mut, mutant; IgG, immunoglobulin G.
    Mouse Anti Human Ago2 Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 412 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+ago2+monoclonal+antibody/Argonaute+2+Rabbit+mAb/pm31638182-151-1-11
    Average 96 stars, based on 412 article reviews
    mouse anti human ago2 monoclonal antibody - by Bioz Stars, 2026-10
    96/100 stars

    Images

    1) Product Images from "Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis."

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.

    Journal: International journal of oncology

    doi: 10.3892/ijo.2019.4887

    Figure 9. Anisomycin attenuates the molecular sponge effect in the lncRNA‑Meg3/miR‑421/PDGFRA axis. (A) Heatmap showing that the expression of lncRNA‑Meg3 in the anisomycin‑treated group was significantly lower than that of the control group. (B) Expression levels in clinical tumour samples and (C) in xenograft tumours suggest an inverse trend in expression for lncRNA‑Meg3 and miR‑421. (D) Expression levels of miR‑421 in HuOCSCs following anisomycin treatment. **P<0.01 vs. non‑treated (n=4). (E) Schematic of the complementary sites of mature miR‑421 and the 3’UTR of lncRNA‑Meg3 and PDGFRA mRNA. (F) Schematic of the structure of luciferase reporter plasmids. (G) The molecular sponge effect of lncRNA‑Meg3/miR‑421/PDGFRA. (H‑J) Results of the luciferase reporter assays. **P<0.01 vs. blank plasmid (n=3). (K) RIP results revealed that the binding between Meg3 and Ago2 decreased significantly following treatment of HuOCSCs with anisomycin. lncRNA, long non‑coding RNA; Meg3, maternally expressed 3; miR, microRNA; PDGFRA, platelet derived growth factor receptor α; HuOCSCs, human ovarian cancer stem cells; RIP, RNA immunoprecipitation; Ago2, argonaute 2; ORF, open reading frame; UTR, untranslated region; mut, mutant; IgG, immunoglobulin G.
    Figure Legend Snippet: Figure 9. Anisomycin attenuates the molecular sponge effect in the lncRNA‑Meg3/miR‑421/PDGFRA axis. (A) Heatmap showing that the expression of lncRNA‑Meg3 in the anisomycin‑treated group was significantly lower than that of the control group. (B) Expression levels in clinical tumour samples and (C) in xenograft tumours suggest an inverse trend in expression for lncRNA‑Meg3 and miR‑421. (D) Expression levels of miR‑421 in HuOCSCs following anisomycin treatment. **P<0.01 vs. non‑treated (n=4). (E) Schematic of the complementary sites of mature miR‑421 and the 3’UTR of lncRNA‑Meg3 and PDGFRA mRNA. (F) Schematic of the structure of luciferase reporter plasmids. (G) The molecular sponge effect of lncRNA‑Meg3/miR‑421/PDGFRA. (H‑J) Results of the luciferase reporter assays. **P<0.01 vs. blank plasmid (n=3). (K) RIP results revealed that the binding between Meg3 and Ago2 decreased significantly following treatment of HuOCSCs with anisomycin. lncRNA, long non‑coding RNA; Meg3, maternally expressed 3; miR, microRNA; PDGFRA, platelet derived growth factor receptor α; HuOCSCs, human ovarian cancer stem cells; RIP, RNA immunoprecipitation; Ago2, argonaute 2; ORF, open reading frame; UTR, untranslated region; mut, mutant; IgG, immunoglobulin G.

    Techniques Used: Expressing, Control, Luciferase, Plasmid Preparation, Binding Assay, Derivative Assay, RNA Immunoprecipitation, Mutagenesis

    Related Articles

    Expressing:

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.
    Article Snippet: After lysis, each sample was centrifuged at 4˚C, 1,200 x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube.x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µg of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3/miR-421/PDGFRA axis
    Article Snippet: After lysis, each sample was centrifuged at 4°C, 1,200 × g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube.g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µ g of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Control:

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.
    Article Snippet: After lysis, each sample was centrifuged at 4˚C, 1,200 x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube.x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µg of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3/miR-421/PDGFRA axis
    Article Snippet: After lysis, each sample was centrifuged at 4°C, 1,200 × g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube.g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µ g of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Luciferase:

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.
    Article Snippet: After lysis, each sample was centrifuged at 4˚C, 1,200 x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube.x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µg of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3/miR-421/PDGFRA axis
    Article Snippet: After lysis, each sample was centrifuged at 4°C, 1,200 × g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube.g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µ g of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Plasmid Preparation:

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.
    Article Snippet: After lysis, each sample was centrifuged at 4˚C, 1,200 x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube.x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µg of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3/miR-421/PDGFRA axis
    Article Snippet: After lysis, each sample was centrifuged at 4°C, 1,200 × g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube.g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µ g of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Binding Assay:

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.
    Article Snippet: After lysis, each sample was centrifuged at 4˚C, 1,200 x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube.x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µg of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3/miR-421/PDGFRA axis
    Article Snippet: After lysis, each sample was centrifuged at 4°C, 1,200 × g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube.g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µ g of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Derivative Assay:

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.
    Article Snippet: After lysis, each sample was centrifuged at 4˚C, 1,200 x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube.x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µg of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3/miR-421/PDGFRA axis
    Article Snippet: After lysis, each sample was centrifuged at 4°C, 1,200 × g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube.g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µ g of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    RNA Immunoprecipitation:

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.
    Article Snippet: After lysis, each sample was centrifuged at 4˚C, 1,200 x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube.x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µg of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3/miR-421/PDGFRA axis
    Article Snippet: After lysis, each sample was centrifuged at 4°C, 1,200 × g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube.g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µ g of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Mutagenesis:

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.
    Article Snippet: After lysis, each sample was centrifuged at 4˚C, 1,200 x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube.x g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µg protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4˚C, followed by centrifugation (4˚C, 450 x g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µg of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3/miR-421/PDGFRA axis
    Article Snippet: After lysis, each sample was centrifuged at 4°C, 1,200 × g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube.g for 10 min to clear the insoluble debris and the supernatant was pre-incubated with 20 µ g protein A agarose beads (Beyotime institute of Biotechnology) by rocking for 30 min at 4°C, followed by centrifugation (4°C, 450 × g for 2 min) and transfer to a new 1.5 ml tube. ... The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 µ g of protein A agarose beads to capture the immune complexes.. The agarose beads were then washed three times with ice-cold homogenization buffer.The agarose beads were then washed three times with ice-cold homogenization buffer.



    Similar Products

    mouse monoclonal anti human ago2 antibody  (Bio-Techne corporation)
    93
    Bio-Techne corporation mouse monoclonal anti human ago2 antibody
    Upregulation of pro-apoptotic FOXO1 in ox-LDL treated HUVECs or HAECs is due to transcriptional regulation and reduction in the miRNA targeting mechanism. (A and B) Cell apoptosis in ox-LDL treated HUVECs or HAECs could be partially relieved by FOXO1 knockdown. (C–E) FOXO1 knockdown drastically reduced FOXO1 mRNA and protein expression levels in the HUVECs or HAECs with or without ox-LDL treatment. (F) FOXO1 promoter reporter assay suggests a mild upregulation of FOXO1 gene transcription. (G–J) <t>AGO2-RIP</t> assay shows that FOXO1 mRNA, miR-183-5p, miR-96-5p and miR-182-5p were downregulated in AGO2 co-immunoprecipitated complexes after ox-LDL treatment. *, p < 0.05; ***, p < 0.001; ****, p < 0.0001.
    Mouse Monoclonal Anti Human Ago2 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+ago2+monoclonal+antibody/Ago2%2FeIF2C2+Antibody+(2E12-1C9)/pmc09087689-56-1-7
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti human ago2 antibody - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    mouse anti-human ago2 monoclonal antibody  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology mouse anti-human ago2 monoclonal antibody
    Upregulation of pro-apoptotic FOXO1 in ox-LDL treated HUVECs or HAECs is due to transcriptional regulation and reduction in the miRNA targeting mechanism. (A and B) Cell apoptosis in ox-LDL treated HUVECs or HAECs could be partially relieved by FOXO1 knockdown. (C–E) FOXO1 knockdown drastically reduced FOXO1 mRNA and protein expression levels in the HUVECs or HAECs with or without ox-LDL treatment. (F) FOXO1 promoter reporter assay suggests a mild upregulation of FOXO1 gene transcription. (G–J) <t>AGO2-RIP</t> assay shows that FOXO1 mRNA, miR-183-5p, miR-96-5p and miR-182-5p were downregulated in AGO2 co-immunoprecipitated complexes after ox-LDL treatment. *, p < 0.05; ***, p < 0.001; ****, p < 0.0001.
    Mouse Anti Human Ago2 Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+ago2+monoclonal+antibody/ago2+sirna/pmc08979684-60-1-9
    Average 90 stars, based on 1 article reviews
    mouse anti-human ago2 monoclonal antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    mouse anti human ago2 monoclonal antibody  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc mouse anti human ago2 monoclonal antibody
    Figure 9. Anisomycin attenuates the molecular sponge effect in the lncRNA‑Meg3/miR‑421/PDGFRA axis. (A) Heatmap showing that the expression of lncRNA‑Meg3 in the anisomycin‑treated group was significantly lower than that of the control group. (B) Expression levels in clinical tumour samples and (C) in xenograft tumours suggest an inverse trend in expression for lncRNA‑Meg3 and miR‑421. (D) Expression levels of miR‑421 in HuOCSCs following anisomycin treatment. **P<0.01 vs. non‑treated (n=4). (E) Schematic of the complementary sites of mature miR‑421 and the 3’UTR of lncRNA‑Meg3 and PDGFRA mRNA. (F) Schematic of the structure of luciferase reporter plasmids. (G) The molecular sponge effect of lncRNA‑Meg3/miR‑421/PDGFRA. (H‑J) Results of the luciferase reporter assays. **P<0.01 vs. blank plasmid (n=3). (K) RIP results revealed that the binding between Meg3 and <t>Ago2</t> decreased significantly following treatment of HuOCSCs with anisomycin. lncRNA, long non‑coding RNA; Meg3, maternally expressed 3; miR, microRNA; PDGFRA, platelet derived growth factor receptor α; HuOCSCs, human ovarian cancer stem cells; RIP, RNA immunoprecipitation; Ago2, argonaute 2; ORF, open reading frame; UTR, untranslated region; mut, mutant; IgG, immunoglobulin G.
    Mouse Anti Human Ago2 Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+ago2+monoclonal+antibody/Argonaute+2+Rabbit+mAb/pm31638182-151-1-11
    Average 96 stars, based on 1 article reviews
    mouse anti human ago2 monoclonal antibody - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    mouse anti human ago2 monoclonal antibody  (FUJIFILM)
    90
    FUJIFILM mouse anti human ago2 monoclonal antibody
    Figure 9. Anisomycin attenuates the molecular sponge effect in the lncRNA‑Meg3/miR‑421/PDGFRA axis. (A) Heatmap showing that the expression of lncRNA‑Meg3 in the anisomycin‑treated group was significantly lower than that of the control group. (B) Expression levels in clinical tumour samples and (C) in xenograft tumours suggest an inverse trend in expression for lncRNA‑Meg3 and miR‑421. (D) Expression levels of miR‑421 in HuOCSCs following anisomycin treatment. **P<0.01 vs. non‑treated (n=4). (E) Schematic of the complementary sites of mature miR‑421 and the 3’UTR of lncRNA‑Meg3 and PDGFRA mRNA. (F) Schematic of the structure of luciferase reporter plasmids. (G) The molecular sponge effect of lncRNA‑Meg3/miR‑421/PDGFRA. (H‑J) Results of the luciferase reporter assays. **P<0.01 vs. blank plasmid (n=3). (K) RIP results revealed that the binding between Meg3 and <t>Ago2</t> decreased significantly following treatment of HuOCSCs with anisomycin. lncRNA, long non‑coding RNA; Meg3, maternally expressed 3; miR, microRNA; PDGFRA, platelet derived growth factor receptor α; HuOCSCs, human ovarian cancer stem cells; RIP, RNA immunoprecipitation; Ago2, argonaute 2; ORF, open reading frame; UTR, untranslated region; mut, mutant; IgG, immunoglobulin G.
    Mouse Anti Human Ago2 Monoclonal Antibody, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+ago2+monoclonal+antibody/anti+ago2/us10532068-540-26-31
    Average 90 stars, based on 1 article reviews
    mouse anti human ago2 monoclonal antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    monoclonal mouse anti-human ago2 clone 2e12-1c9  (Abnova)
    90
    Abnova monoclonal mouse anti-human ago2 clone 2e12-1c9
    (A) Western blot of <t>Ago2</t> protein in the Ago2- and IgG-immunoprecipitation. M marker; T Total fraction; FT Flow through fraction; IP Immunoprecipitation fraction. Arrow indicates the Ago2 protein. Ago2 protein can be detected in the Ago2-IP fraction, while it cannot be detected in the IgG 1 -IP fraction. (B) To confirm miRNA enrichment in the IP fraction, qRT-PCR was performed for three randomly selected miRNAs expressed in lung fibroblasts, i.e. miR-31-5p, miR-455-3p and miR-199b. The levels of these miRNAs are strongly increased in the Ago2-IP fraction compared to the IgG 1 -IP fraction.
    Monoclonal Mouse Anti Human Ago2 Clone 2e12 1c9, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+ago2+monoclonal+antibody/anti+ago2+antibody/pmc05599028-303-6-12
    Average 90 stars, based on 1 article reviews
    monoclonal mouse anti-human ago2 clone 2e12-1c9 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    human p4 anti-mouse ago2 monoclonal antibody 2d4  (FUJIFILM)
    90
    FUJIFILM human p4 anti-mouse ago2 monoclonal antibody 2d4
    (A) Western blot of <t>Ago2</t> protein in the Ago2- and IgG-immunoprecipitation. M marker; T Total fraction; FT Flow through fraction; IP Immunoprecipitation fraction. Arrow indicates the Ago2 protein. Ago2 protein can be detected in the Ago2-IP fraction, while it cannot be detected in the IgG 1 -IP fraction. (B) To confirm miRNA enrichment in the IP fraction, qRT-PCR was performed for three randomly selected miRNAs expressed in lung fibroblasts, i.e. miR-31-5p, miR-455-3p and miR-199b. The levels of these miRNAs are strongly increased in the Ago2-IP fraction compared to the IgG 1 -IP fraction.
    Human P4 Anti Mouse Ago2 Monoclonal Antibody 2d4, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+ago2+monoclonal+antibody/anti+ago2/10__5772_slash_53803-49-13-21
    Average 90 stars, based on 1 article reviews
    human p4 anti-mouse ago2 monoclonal antibody 2d4 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    mouse monoclonal antibody against human ago2  (Danaher Inc)
    99
    Danaher Inc mouse monoclonal antibody against human ago2
    (A) Western blot of <t>Ago2</t> protein in the Ago2- and IgG-immunoprecipitation. M marker; T Total fraction; FT Flow through fraction; IP Immunoprecipitation fraction. Arrow indicates the Ago2 protein. Ago2 protein can be detected in the Ago2-IP fraction, while it cannot be detected in the IgG 1 -IP fraction. (B) To confirm miRNA enrichment in the IP fraction, qRT-PCR was performed for three randomly selected miRNAs expressed in lung fibroblasts, i.e. miR-31-5p, miR-455-3p and miR-199b. The levels of these miRNAs are strongly increased in the Ago2-IP fraction compared to the IgG 1 -IP fraction.
    Mouse Monoclonal Antibody Against Human Ago2, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+ago2+monoclonal+antibody/mouse+monoclonal+Anti-SOX2+antibody/pm20198652-57-14-20
    Average 99 stars, based on 1 article reviews
    mouse monoclonal antibody against human ago2 - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Upregulation of pro-apoptotic FOXO1 in ox-LDL treated HUVECs or HAECs is due to transcriptional regulation and reduction in the miRNA targeting mechanism. (A and B) Cell apoptosis in ox-LDL treated HUVECs or HAECs could be partially relieved by FOXO1 knockdown. (C–E) FOXO1 knockdown drastically reduced FOXO1 mRNA and protein expression levels in the HUVECs or HAECs with or without ox-LDL treatment. (F) FOXO1 promoter reporter assay suggests a mild upregulation of FOXO1 gene transcription. (G–J) AGO2-RIP assay shows that FOXO1 mRNA, miR-183-5p, miR-96-5p and miR-182-5p were downregulated in AGO2 co-immunoprecipitated complexes after ox-LDL treatment. *, p < 0.05; ***, p < 0.001; ****, p < 0.0001.

    Journal: RSC Advances

    Article Title: miR-183-96-182 clusters alleviated ox-LDL-induced vascular endothelial cell apoptosis in vitro by targeting FOXO1

    doi: 10.1039/c8ra06866f

    Figure Lengend Snippet: Upregulation of pro-apoptotic FOXO1 in ox-LDL treated HUVECs or HAECs is due to transcriptional regulation and reduction in the miRNA targeting mechanism. (A and B) Cell apoptosis in ox-LDL treated HUVECs or HAECs could be partially relieved by FOXO1 knockdown. (C–E) FOXO1 knockdown drastically reduced FOXO1 mRNA and protein expression levels in the HUVECs or HAECs with or without ox-LDL treatment. (F) FOXO1 promoter reporter assay suggests a mild upregulation of FOXO1 gene transcription. (G–J) AGO2-RIP assay shows that FOXO1 mRNA, miR-183-5p, miR-96-5p and miR-182-5p were downregulated in AGO2 co-immunoprecipitated complexes after ox-LDL treatment. *, p < 0.05; ***, p < 0.001; ****, p < 0.0001.

    Article Snippet: A mouse monoclonal anti-human AGO2 antibody (H00027161-M01, Bio-techne) was incubated at 1 : 100 ratio with cell lysate for 2 hours at 4 °C with gentle agitation, followed by incubation with Pierce™ Protein A/G Magnetic Beads (Thermo Fisher Scientific) for another 2 hours at 4 °C with gentle agitation.

    Techniques: Expressing, Reporter Assay, Immunoprecipitation

    Figure 9. Anisomycin attenuates the molecular sponge effect in the lncRNA‑Meg3/miR‑421/PDGFRA axis. (A) Heatmap showing that the expression of lncRNA‑Meg3 in the anisomycin‑treated group was significantly lower than that of the control group. (B) Expression levels in clinical tumour samples and (C) in xenograft tumours suggest an inverse trend in expression for lncRNA‑Meg3 and miR‑421. (D) Expression levels of miR‑421 in HuOCSCs following anisomycin treatment. **P<0.01 vs. non‑treated (n=4). (E) Schematic of the complementary sites of mature miR‑421 and the 3’UTR of lncRNA‑Meg3 and PDGFRA mRNA. (F) Schematic of the structure of luciferase reporter plasmids. (G) The molecular sponge effect of lncRNA‑Meg3/miR‑421/PDGFRA. (H‑J) Results of the luciferase reporter assays. **P<0.01 vs. blank plasmid (n=3). (K) RIP results revealed that the binding between Meg3 and Ago2 decreased significantly following treatment of HuOCSCs with anisomycin. lncRNA, long non‑coding RNA; Meg3, maternally expressed 3; miR, microRNA; PDGFRA, platelet derived growth factor receptor α; HuOCSCs, human ovarian cancer stem cells; RIP, RNA immunoprecipitation; Ago2, argonaute 2; ORF, open reading frame; UTR, untranslated region; mut, mutant; IgG, immunoglobulin G.

    Journal: International journal of oncology

    Article Title: Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.

    doi: 10.3892/ijo.2019.4887

    Figure Lengend Snippet: Figure 9. Anisomycin attenuates the molecular sponge effect in the lncRNA‑Meg3/miR‑421/PDGFRA axis. (A) Heatmap showing that the expression of lncRNA‑Meg3 in the anisomycin‑treated group was significantly lower than that of the control group. (B) Expression levels in clinical tumour samples and (C) in xenograft tumours suggest an inverse trend in expression for lncRNA‑Meg3 and miR‑421. (D) Expression levels of miR‑421 in HuOCSCs following anisomycin treatment. **P<0.01 vs. non‑treated (n=4). (E) Schematic of the complementary sites of mature miR‑421 and the 3’UTR of lncRNA‑Meg3 and PDGFRA mRNA. (F) Schematic of the structure of luciferase reporter plasmids. (G) The molecular sponge effect of lncRNA‑Meg3/miR‑421/PDGFRA. (H‑J) Results of the luciferase reporter assays. **P<0.01 vs. blank plasmid (n=3). (K) RIP results revealed that the binding between Meg3 and Ago2 decreased significantly following treatment of HuOCSCs with anisomycin. lncRNA, long non‑coding RNA; Meg3, maternally expressed 3; miR, microRNA; PDGFRA, platelet derived growth factor receptor α; HuOCSCs, human ovarian cancer stem cells; RIP, RNA immunoprecipitation; Ago2, argonaute 2; ORF, open reading frame; UTR, untranslated region; mut, mutant; IgG, immunoglobulin G.

    Article Snippet: The mouse anti-human Ago2 monoclonal antibody (clone C34C6; cat no. 2897; Cell Signaling Technology, Inc.; 1:100) was added for 90 min, before the re-addition of 20 μg of protein A agarose beads to capture the immune complexes.

    Techniques: Expressing, Control, Luciferase, Plasmid Preparation, Binding Assay, Derivative Assay, RNA Immunoprecipitation, Mutagenesis

    (A) Western blot of Ago2 protein in the Ago2- and IgG-immunoprecipitation. M marker; T Total fraction; FT Flow through fraction; IP Immunoprecipitation fraction. Arrow indicates the Ago2 protein. Ago2 protein can be detected in the Ago2-IP fraction, while it cannot be detected in the IgG 1 -IP fraction. (B) To confirm miRNA enrichment in the IP fraction, qRT-PCR was performed for three randomly selected miRNAs expressed in lung fibroblasts, i.e. miR-31-5p, miR-455-3p and miR-199b. The levels of these miRNAs are strongly increased in the Ago2-IP fraction compared to the IgG 1 -IP fraction.

    Journal: PLoS ONE

    Article Title: Identification of transforming growth factor-beta-regulated microRNAs and the microRNA-targetomes in primary lung fibroblasts

    doi: 10.1371/journal.pone.0183815

    Figure Lengend Snippet: (A) Western blot of Ago2 protein in the Ago2- and IgG-immunoprecipitation. M marker; T Total fraction; FT Flow through fraction; IP Immunoprecipitation fraction. Arrow indicates the Ago2 protein. Ago2 protein can be detected in the Ago2-IP fraction, while it cannot be detected in the IgG 1 -IP fraction. (B) To confirm miRNA enrichment in the IP fraction, qRT-PCR was performed for three randomly selected miRNAs expressed in lung fibroblasts, i.e. miR-31-5p, miR-455-3p and miR-199b. The levels of these miRNAs are strongly increased in the Ago2-IP fraction compared to the IgG 1 -IP fraction.

    Article Snippet: Cell lysates were incubated overnight with monoclonal mouse anti-human Ago2 (Clone 2E12-1C9, Abnova, Taipei City, Taiwan) coated Sepharose G beads (Abcam, Cambridge, UK).

    Techniques: Western Blot, Immunoprecipitation, Marker, Quantitative RT-PCR

    For each miRNA, the percentages of predicted targets were calculated in all expressed genes and in the top 1,500 most IP-enriched genes in all four IP experiments. Chi-square test was used to determine whether the number of predicted targets in the Ago2-IP fraction for miR-455-3p and miR-21-3p in the top 1,500 most enriched genes was significant different from the expected based on the number of predicted targets in all expressed genes.

    Journal: PLoS ONE

    Article Title: Identification of transforming growth factor-beta-regulated microRNAs and the microRNA-targetomes in primary lung fibroblasts

    doi: 10.1371/journal.pone.0183815

    Figure Lengend Snippet: For each miRNA, the percentages of predicted targets were calculated in all expressed genes and in the top 1,500 most IP-enriched genes in all four IP experiments. Chi-square test was used to determine whether the number of predicted targets in the Ago2-IP fraction for miR-455-3p and miR-21-3p in the top 1,500 most enriched genes was significant different from the expected based on the number of predicted targets in all expressed genes.

    Article Snippet: Cell lysates were incubated overnight with monoclonal mouse anti-human Ago2 (Clone 2E12-1C9, Abnova, Taipei City, Taiwan) coated Sepharose G beads (Abcam, Cambridge, UK).

    Techniques:

    Most enriched biological processes/pathways within the Ago2-IP enriched and TargetScan predicted miR-455-3p target genes.

    Journal: PLoS ONE

    Article Title: Identification of transforming growth factor-beta-regulated microRNAs and the microRNA-targetomes in primary lung fibroblasts

    doi: 10.1371/journal.pone.0183815

    Figure Lengend Snippet: Most enriched biological processes/pathways within the Ago2-IP enriched and TargetScan predicted miR-455-3p target genes.

    Article Snippet: Cell lysates were incubated overnight with monoclonal mouse anti-human Ago2 (Clone 2E12-1C9, Abnova, Taipei City, Taiwan) coated Sepharose G beads (Abcam, Cambridge, UK).

    Techniques: Gene Expression, Activity Assay, Cell Differentiation, Activation Assay, In Utero, De-Phosphorylation Assay

    Most enriched biological processes/pathways within the Ago2-IP enriched and TargetScan predicted miR-21-3p target genes.

    Journal: PLoS ONE

    Article Title: Identification of transforming growth factor-beta-regulated microRNAs and the microRNA-targetomes in primary lung fibroblasts

    doi: 10.1371/journal.pone.0183815

    Figure Lengend Snippet: Most enriched biological processes/pathways within the Ago2-IP enriched and TargetScan predicted miR-21-3p target genes.

    Article Snippet: Cell lysates were incubated overnight with monoclonal mouse anti-human Ago2 (Clone 2E12-1C9, Abnova, Taipei City, Taiwan) coated Sepharose G beads (Abcam, Cambridge, UK).

    Techniques: Activity Assay, Modification, Ubiquitin Proteomics, Phospho-proteomics, Activation Assay, Clinical Proteomics, Membrane, Starch